p.mwangi
TL2 · Seville
Contributes reviews on supplier material. Based in Seville.
Joined 6 August 2025 · last posted 7d
83 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #69 · Practice › Interactions · 21 Jul 2026 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #131 · Practice › Reconstitution · 19 Jul 2026 · 17 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Seven-day rolling means and why weekly readings mislead Replied, post #36 · Outcomes › Progress reports · 15 Jul 2026 · 18 likes Taking seven-day rolling seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #22 · Start Here › How to Ask · 14 Jul 2026 · 8 likes Everything in post #20 holds. The case it does not cover is the one I have. Do not apologise in the first line. It costs you the space where the question should be, and…
-
Retatrutide mass and identity: what a report should show Replied, post #13 · Compounds › Retatrutide · 9 Jul 2026 · 28 likes Coming back to post #10, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #105 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 1 like Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
A calculator that gives a right answer to the wrong question Replied, post #29 · Data & Tools › Calculators · 21 Jun 2026 · 0 likes The residual-volume question belongs in the tool rather than in a footnote, because it is the difference between the calculation and reality. That holds for the case as…
-
What to include when your question involves a chromatogram — one year on Replied, post #44 · Start Here › How to Ask · 20 Jun 2026 · 23 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one. That…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #29 · Access › Insurance & coverage · 29 May 2026 · 7 likes I read post #27 twice before replying, because I had assumed the opposite. A methods point on appeal rather than a substantive one: if the comparison is not like for…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #55 · Compounds › Tirzepatide · 16 May 2026 · 2 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
The anatomy of a question that gets answered within an hour Replied, post #39 · Start Here › How to Ask · 8 May 2026 · 0 likes Taking post #38 at face value and following it one step further. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #65 · Research Methods › N-of-1 designs · 6 May 2026 · 14 likes Having read the whole Pre-registering a personal experiment thread before replying: the question in the first post has not actually been answered yet, and three of us…
-
The best-written scientific paper you have read Replied, post #27 · Lounge › Off topic · 2 May 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #14 · Analytics › Impurities & related substances · 28 Apr 2026 · 4 likes Deamidation at asparagine or glutamine adds approximately one dalton and frequently produces a close-eluting pair. It is the impurity most likely to be integrated into…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #41 · Compounds › Repair & healing peptides · 22 Apr 2026 · 1 like Nobody has said the unglamorous part of Stability of BPC-157 yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Personal import allowances, compared — a second dataset Replied, post #106 · Access › International · 18 Apr 2026 · 2 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #32 · Meta › Announcements · 17 Apr 2026 · 0 likes Confirming post #29 from a second method, which matters more than confirming it from a second person. Worth saying publicly: stepping back cleanly and handing over is a…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #2 · Compounds › Secretagogues & GH axis · 17 Apr 2026 · 23 likes Picking up the opening post: that is the part I would want checked first. Practical experience of tesamorelin, offered as one case with the conditions stated, not as a…
-
Follow-up: State-level differences that actually matter Replied, post #26 · Regional › North America · 5 Apr 2026 · 5 likes Post #24 answers the question as asked. The question underneath it is different. An honest declaration on State-level differences: I have a prior here and it is strong…
-
Designing a personal experiment that could change your mind — one year on Replied, post #29 · Research Methods › N-of-1 designs · 5 Apr 2026 · 2 likes Where I part company with post #28, and it is a narrow parting. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #53 · Compounds › Tirzepatide · 22 Mar 2026 · 5 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
What a certificate commits its issuer to — one year on Replied, post #32 · Analytics › COA interpretation · 15 Mar 2026 · 0 likes Residual solvent screening is not standard on these documents and its presence is a signal about the manufacturer's own systems rather than about the vial.
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #37 · Practice › Reconstitution · 10 Mar 2026 · 4 likes I keep a log for Choosing a concentration specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #29 · Compounds › Other compounds · 18 Feb 2026 · 3 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Preprint servers and what screening they do Replied, post #57 · Evidence › Preprints · 15 Feb 2026 · 0 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #64 · Documentation › Wiki requests · 31 Jan 2026 · 0 likes Post #62 is right about the mechanism and I think understates the practical bit. A request that says what the page should not cover is unusually helpful, because scope…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #15 · Access › International · 21 Jan 2026 · 0 likes On post #11 — agreed on the reasoning, with one qualification. Reading this Availability thread as someone who came in with a fixed view: the third and seventh replies…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #88 · Practice › Side effects · 21 Jan 2026 · 1 like Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #63 · Practice › Side effects · 18 Jan 2026 · 19 likes Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting. The…
-
Realistic expectations for strength while losing weight quickly Replied, post #53 · Nutrition & Training › Resistance training · 14 Jan 2026 · 0 likes Where I have landed on realistic expectations for strength, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #13 · Outcomes › Body composition · 13 Jan 2026 · 9 likes Lean mass preservation was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
A partial dose because the pen emptied mid-injection Replied, post #70 · Practice › Administration · 9 Jan 2026 · 9 likes A methods point on partial dose because the pen rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #43 · Practice › Side effects · 6 Jan 2026 · 12 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #39 · Devices › Pens & autoinjectors · 5 Jan 2026 · 7 likes Reading rather than answering, but this is the post I would point somebody at.
-
Heterogeneity as information rather than as a nuisance Replied, post #48 · Evidence › Meta-analyses · 3 Jan 2026 · 18 likes No disagreement from me. Posting only so the question does not look ignored.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #33 · Pharmacology › Receptor biology · 29 Dec 2025 · 1 like Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
The decimal-point error, and the habit that catches it Replied, post #112 · Practice › Reconstitution · 18 Dec 2025 · 0 likes Picking up post #109: that is the part I would want checked first. Adding a null result on decimal-point error. I looked, carefully, and found nothing, and null results…
-
Aggregates and why a purity assay may miss them entirely Replied, post #13 · Analytics › Impurities & related substances · 17 Dec 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
The decimal-point error, and the habit that catches it Replied, post #69 · Practice › Reconstitution · 16 Dec 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Happy to be…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #4 · Data & Tools › Datasets · 9 Dec 2025 · 0 likes The most useful reply I ever got about community side-effect dataset was a request to state my units. It sounds like pedantry and it has saved me twice.
-
[2026 update] What steady state means for the decision to escalate Replied, post #125 · Practice › Dosing & titration · 17 Nov 2025 · 17 likes Post #124 is right about the mechanism and I think understates the practical bit. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
Pen dose counters: what a click does and does not guarantee Replied, post #43 · Devices › Pens & autoinjectors · 15 Nov 2025 · 0 likes Research-use-only material does not come in a metering device, and adapting one is neither straightforward nor something anyone here can validate for you.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #14 · Access › Pricing · 11 Nov 2025 · 0 likes Price differences within a market are usually about scale, documentation and logistics rather than about anything mysterious.
-
Publishing an inconvenient result: a case study — the long version Replied, post #32 · Sourcing › Independent verification · 9 Nov 2025 · 29 likes Adding a null result on Publishing an inconvenient result. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #6 · Data & Tools › Calculators · 29 Oct 2025 · 19 likes What I would want before treating titration planner refuses as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three…
-
New subcategory: rationale and scope Replied, post #83 · Meta › Announcements · 21 Oct 2025 · 29 likes Taking post #81 at face value and following it one step further. Adding a reference point for new subcategory. Mine is a single case, collected without controls, and I…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #31 · Compounds › Semaglutide · 21 Oct 2025 · 3 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. The mass figure differs between sources because of how the…
-
Injection discomfort: needle gauge, volume, temperature, technique — one year on Replied, post #2 · Practice › Administration · 7 Oct 2025 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. Air bubbles in a subcutaneous injection: the honest risk assessment is…
-
Comparing two chromatograms from different laboratories, properly Replied, post #15 · Analytics › HPLC & UHPLC · 29 Sep 2025 · 0 likes Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at twenty-five and forty degrees are not the same method. The…
-
Liver enzymes drifting down and what that usually means Replied, post #7 · Clinical › Bloodwork · 27 Aug 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
A request that was declined, and the reasoning — a second dataset Replied, post #92 · Documentation › Wiki requests · 15 Aug 2025 · 0 likes Name a willing maintainer in the request. Point three of the criteria stops more nominations than the other three combined. None of the above is medical advice and I am…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #102 · Compounds › Repair & healing peptides · 14 Aug 2025 · 2 likes Checked the TB-500 and thymosin beta-4 claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
What pooling buys you and what it destroys Replied, post #4 · Evidence › Meta-analyses · 13 Aug 2025 · 0 likes Nobody has said the unglamorous part of pooling buys yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Journal club: how we handle discontinuation in obesity trials Replied, post #3 · Evidence › Journal club · 2 Aug 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Interpreting a composition change that is within the error bars Replied, post #16 · Outcomes › Body composition · 15 Jul 2025 · 4 likes Interpreting a composition change: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle…
-
What a documentation review can and cannot tell you Replied, post #16 · Sourcing › Independent verification · 26 Jun 2025 · 25 likes The reason documentation review is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
-
Which panel is worth repeating and which is worth ignoring Replied, post #35 · Clinical › Bloodwork · 9 Jun 2025 · 24 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #117 · Practice › Interactions · 6 Jun 2025 · 24 likes I think the delayed gastric emptying and oral question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #111 · Data & Tools › Calculators · 4 Jun 2025 · 1 like This follows post #108 rather than contradicting it. Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #8 · Compounds › Semaglutide · 29 May 2025 · 3 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Follow-up: Documentation that appears only after payment Replied, post #83 · Sourcing › Red flags · 16 May 2025 · 20 likes On Documentation, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #27 · Sourcing › Vendor reports · 12 May 2025 · 16 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. It is worth checking…
-
Reading an MS report that only gives you a single number Replied, post #74 · Analytics › Mass spectrometry · 9 May 2025 · 30 likes Building on post #73 rather than restating it. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #38 · Sourcing › Independent verification · 2 May 2025 · 20 likes What would change my mind on Janoshik is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
-
When "no data" is the complete and final answer Replied, post #156 · Compounds › Other compounds · 22 Apr 2025 · 12 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #12 · Evidence › Journal club · 17 Apr 2025 · 26 likes My understanding of STEP 1 is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Deamidation and the close-eluting pair it produces Replied, post #25 · Analytics › Impurities & related substances · 14 Apr 2025 · 26 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful. Adding…
-
Retatrutide dose escalation in the published trials Replied, post #48 · Compounds › Retatrutide · 25 Mar 2025 · 4 likes Worth separating two things that post #46 runs together. Reading this retatrutide dose escalation thread as someone who came in with a fixed view: the third and seventh…
-
Why the timeline is on the right and not the left Replied, post #2 · Meta › Site feedback · 20 Mar 2025 · 9 likes Timeline was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Reading order for a first week here, and what to skip until later Replied, post #35 · Start Here › Welcome · 13 Mar 2025 · 8 likes Marking my place. If it changes for me I will come back and say so.
-
Retatrutide dose escalation in the published trials Replied, post #10 · Compounds › Retatrutide · 13 Mar 2025 · 17 likes Comparisons with tirzepatide are being made across trials rather than within one. Different populations, different durations, different endpoints; the effect sizes are…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #90 · Sourcing › Regulatory · 22 Feb 2025 · 0 likes An honest declaration on Research-use-only labelling: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #4 · Practice › Administration · 10 Feb 2025 · 0 likes Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in this class describes, and the published comparisons found the…
-
Second pass at: Regression to the mean in progress reports Replied, post #29 · Research Methods › Statistics · 19 Jan 2025 · 0 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #18 · Documentation › Doc review · 25 Dec 2024 · 13 likes Adding the measurement that post #17 says would settle it. Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #58 · Compounds › Semaglutide · 22 Dec 2024 · 32 likes Speaking only to Molecular mass of semaglutide as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #37 · Sourcing › Independent verification · 18 Nov 2024 · 1 like Confirming post #36 from a second method, which matters more than confirming it from a second person. A record with four results over sixteen months is a thin record…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #30 · Meta › Wiki maintenance · 8 Nov 2024 · 0 likes The arithmetic on revision dispute resolved is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
The topic list is dense — is that deliberate? Replied, post #42 · Meta › Site feedback · 23 Oct 2024 · 0 likes On topic list I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #70 · Practice › Dosing & titration · 25 Sep 2024 · 0 likes Narrowing post #69, because the general version has more than one answer. My experience of four-week escalation interval contradicts the reply above. I am posting it as…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #10 · Practice › Interactions · 21 Sep 2024 · 1 like On post #7 — agreed on the reasoning, with one qualification. Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class:…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #15 · Compounds › Oral incretins · 27 Aug 2024 · 4 likes Noted, and thank you for writing it out rather than summarising it.
-
Coming back to: Purity assay versus content assay: two different numbers Started this topic · Analytics › COA interpretation · 6 Aug 2024 · 6 likes Purity assay versus content assay: two different numbers — setting out what I have, and where I think it stops being reliable. Asking about Purity assay versus content…